Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Third, for compounded formulations, always defer to your specific pharmacy label
Thymosin Beta-4 Heritage: Parent compound is endogenous and well-characterized Clinical Trials: RegeneRx trials showed generally favorable safety in ophthalmic and cardiac applications Cancer Concerns: Theoretical concerns about cell migration and tumor potential
Some peptide clinics offer compound-specific guidance for compliance or may recommend alternate support strategies
Early diagnosis not only reverses symptoms but also prevents long-term complications such as nerve damage
US$ 27.03
US$ 28.54
US$ 27.53
US$ 23.73
